Literature DB >> 27714630

Low-Intensity Ultrasound Decreases α-Synuclein Aggregation via Attenuation of Mitochondrial Reactive Oxygen Species in MPP(+)-Treated PC12 Cells.

Mrigendra Bir Karmacharya1, Binika Hada2, So Ra Park3, Byung Hyune Choi4.   

Abstract

Many studies have shown that mitochondrial dysfunction and the subsequent oxidative stress caused by excessive reactive oxygen species (ROS) generation play a central role in the pathogenesis of Parkinson's disease (PD). We have previously shown that low-intensity ultrasound (LIUS) could reduce ROS generation by L-buthionine-(S,R)-sulfoximine (BSO) in retinal pigment epithelial cells. In this study, we studied the effects of LIUS stimulation on the ROS-dependent α-synuclein aggregation in 1-methyl-4-phenylpyridinium ion (MPP+)-treated PC12 cells. We found that LIUS stimulation suppressed the MPP+-induced ROS generation and inhibition of mitochondrial complex I activity in PC12 cells in an intensity-dependent manner at 30, 50, and 100 mW/cm2. Furthermore, LIUS stimulation at 100 mW/cm2 suppressed inhibition of mitochondrial complex activity by MPP+ and actually resulted in a decrease of α-synuclein phosphorylation and aggregation induced by MMP+ treatment in PC12 cells. LIUS stimulation also inhibited expression of casein kinase 2 (CK2) that appears to mediate ROS-dependent α-synuclein aggregation. Finally, LIUS stimulation alleviated the death of PC12 cells by MPP+ treatment in an intensity-dependent manner. We, hence, suggest that LIUS stimulation inhibits ROS generation by MPP+ treatment, thereby suppressing α-synuclein aggregation in PC12 cells.

Entities:  

Keywords:  1-Methyl-4-phenylpyridinium ion (MPP+); Low-intensity ultrasound (LIUS); Mitochondrial dysfunction; Parkinson’s disease (PD); Reactive oxygen species (ROS); α-Synuclein

Mesh:

Substances:

Year:  2016        PMID: 27714630     DOI: 10.1007/s12035-016-0104-z

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  44 in total

1.  Anti-inflammatory effect of low intensity ultrasound (LIUS) on complete Freund's adjuvant-induced arthritis synovium.

Authors:  J-I Chung; S Barua; B H Choi; B-H Min; H C Han; E J Baik
Journal:  Osteoarthritis Cartilage       Date:  2012-01-24       Impact factor: 6.576

2.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

3.  Mechanical stimulation evokes rapid increases in extracellular adenosine concentration in the prefrontal cortex.

Authors:  Ashley E Ross; Michael D Nguyen; Eve Privman; B Jill Venton
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

Review 4.  Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease.

Authors:  Steven P Braithwaite; Michael Voronkov; Jeffry B Stock; M Maral Mouradian
Journal:  Neurochem Int       Date:  2012-02-08       Impact factor: 3.921

Review 5.  Toxin models of mitochondrial dysfunction in Parkinson's disease.

Authors:  Terina N Martinez; J Timothy Greenamyre
Journal:  Antioxid Redox Signal       Date:  2011-07-12       Impact factor: 8.401

Review 6.  Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies.

Authors:  Kostas Vekrellis; Leonidas Stefanis
Journal:  Expert Opin Ther Targets       Date:  2012-04       Impact factor: 6.902

Review 7.  Mitochondrial biology and Parkinson's disease.

Authors:  Celine Perier; Miquel Vila
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

8.  alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.

Authors:  Maria Xilouri; Tereza Vogiatzi; Kostas Vekrellis; Leonidas Stefanis
Journal:  Autophagy       Date:  2008-10-26       Impact factor: 16.016

9.  Mechanical stretch induces mitochondria-dependent apoptosis in neonatal rat cardiomyocytes and G2/M accumulation in cardiac fibroblasts.

Authors:  Xu Dong Liao; Xiao Hui Wang; Hai Jing Jin; Lan Ying Chen; Quan Chen
Journal:  Cell Res       Date:  2004-02       Impact factor: 25.617

10.  Rotenone induces neuronal death by microglial phagocytosis of neurons.

Authors:  Julius V Emmrich; Tamara C Hornik; Jonas J Neher; Guy C Brown
Journal:  FEBS J       Date:  2013-07-10       Impact factor: 5.542

View more
  6 in total

Review 1.  Blood-brain barrier opening with focused ultrasound in experimental models of Parkinson's disease.

Authors:  Maria Eleni Karakatsani; Javier Blesa; Elisa Evgenia Konofagou
Journal:  Mov Disord       Date:  2019-07-30       Impact factor: 10.338

Review 2.  Parkinson's disease gene therapy: Will focused ultrasound and nanovectors be the next frontier?

Authors:  Richard J Price; Delaney G Fisher; Jung Soo Suk; Justin Hanes; Han Seok Ko; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2019-03-25       Impact factor: 10.338

3.  Assessment of Neuroprotective Effects of Low-Intensity Transcranial Ultrasound Stimulation in a Parkinson's Disease Rat Model by Fractional Anisotropy and Relaxation Time T2 Value.

Authors:  Yanchao Dong; Defeng Liu; Yuemei Zhao; Yi Yuan; Wenxi Wang; Shuo Wu; Xin Liang; Zhanqiu Wang; Lanxiang Liu
Journal:  Front Neurosci       Date:  2021-02-09       Impact factor: 4.677

Review 4.  Focused Ultrasound Stimulation as a Neuromodulatory Tool for Parkinson's Disease: A Scoping Review.

Authors:  Keng Siang Lee; Benjamin Clennell; Tom G J Steward; Andriana Gialeli; Oscar Cordero-Llana; Daniel J Whitcomb
Journal:  Brain Sci       Date:  2022-02-19

Review 5.  New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases.

Authors:  Marco T Nuñez; Pedro Chana-Cuevas
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-19

Review 6.  Reformulating Pro-Oxidant Microglia in Neurodegeneration.

Authors:  Juan García-Revilla; Isabel M Alonso-Bellido; Miguel A Burguillos; Antonio J Herrera; Ana M Espinosa-Oliva; Rocío Ruiz; Luis Cruz-Hernández; Irene García-Domínguez; María A Roca-Ceballos; Marti Santiago; José A Rodríguez-Gómez; Manuel Sarmiento Soto; José L Venero; Rocío M de Pablos
Journal:  J Clin Med       Date:  2019-10-17       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.